RxDoctor Payments Data

Raj Bose, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tucson, AZNPI 1093787749

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $110,000 of the $118,243 with a category attached, or 93.0%. Saphena Medical, Inc. accounts for 93.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $66,224 and has fallen 99.1% since, to $587 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$118,243in general payments, 2019–2025

Across 138 payments — averaging $856.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saphena Medical, Inc.$110K
  • Medtronic$2K
  • Edwards Lifesciences$1K
  • Abiomed$1K
  • Atricure, Inc.$649
  • Johnson & Johnson$482
  • plus $3K from 20 others
$28,925in research payments, 2019–2025

Across 12 payments — averaging $2410.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Artivion, Inc.$29K

What the payments were for

  • Consulting fees$110,00093%
  • Travel & lodging$1,0841%
  • Food & beverage$7,1396%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$118,243 in reported general payments places this provider in the 90th percentile of 100 thoracic surgery (cardiothoracic vascular surgery) providers in Arizona.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Arizona

Medicare billing

Part B allowed, 2024
$253,017
Medicare patients
219
Services billed
1,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin58$42,219
EntrestoSacubitril/Valsartan24$23,523
Atorvastatin Calcium139$1,101
Carvedilol97$525
Metoprolol Tartrate118$500
Isosorbide Mononitrate ErIsosorbide Mononitrate43$448
Losartan Potassium57$306
Potassium Chloride31$282
ClopidogrelClopidogrel Bisulfate26$248
Furosemide42$227
Metoprolol Succinate26$173
Rosuvastatin Calcium19$80
Hydrochlorothiazide23$52
Amlodipine Besylate22$49

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →